May 29, 2024
- Corporate
Personnel Changes
TOKYO, May 29, 2024 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective July 1, 2024.
[Details of Personnel Changes]
Executive Officers
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Masayoshi Higuchi |
Vice President |
Vice President |
Department Head
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Mamoru Yoshida |
Head of Business Strategy & Compliance Dept., Quality & Regulatory Compliance Unit, |
Head of DX Strategy Planning Group, Business Strategy & Compliance Dept., Quality & Regulatory Compliance Unit, |
Group Companies
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Seiji Ueno |
Vice President |
Head of Manufacturing Science and Technology Dept., Chugai Pharma Manufacturing Co., Ltd. |
| Akira Kurabayashi |
Vice President |
Head of Digital & Engineering Dept., Chugai Pharma Manufacturing Co., Ltd. |
Introduction of executive officer system at Chugai Pharma Manufacturing Co., Ltd.
Chugai Pharmaceutical Manufacturing Co., Ltd. (Head office: Tokyo, President: Kenji Kamada), a member of the Chugai Group, will introduce executive officer system as of July 1, 2024, with the aim of speeding up management decision making and improving the efficiency of business execution.
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Hideki Sato
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
